

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.19158303 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.10005271 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.10005271 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.09391510 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.09391510 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.09391510 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.09391510 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.09391510 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.09391510 |
| 10 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.04447639 |
| 11 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.04447639 |
| 12 | detection of other organism (GO:0098543) | 5.02852860 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.01113698 |
| 14 | negative regulation of phagocytosis (GO:0050765) | 4.94569929 |
| 15 | defense response to fungus (GO:0050832) | 4.89206159 |
| 16 | DNA unwinding involved in DNA replication (GO:0006268) | 4.85856822 |
| 17 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.68504268 |
| 18 | detection of bacterium (GO:0016045) | 4.67729836 |
| 19 | response to fungus (GO:0009620) | 4.52624701 |
| 20 | DNA strand elongation (GO:0022616) | 4.48861702 |
| 21 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.47378952 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 4.36042789 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 4.34541060 |
| 24 | neutrophil mediated immunity (GO:0002446) | 4.34361697 |
| 25 | detection of external biotic stimulus (GO:0098581) | 4.31768723 |
| 26 | leukocyte aggregation (GO:0070486) | 4.26012938 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.05056198 |
| 28 | neutrophil activation (GO:0042119) | 4.03270065 |
| 29 | pentose-phosphate shunt (GO:0006098) | 4.00634158 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96345986 |
| 31 | protein localization to kinetochore (GO:0034501) | 3.94380116 |
| 32 | immunoglobulin mediated immune response (GO:0016064) | 3.94121015 |
| 33 | telomere maintenance via recombination (GO:0000722) | 3.94042205 |
| 34 | detection of biotic stimulus (GO:0009595) | 3.92981757 |
| 35 | disruption of cells of other organism (GO:0044364) | 3.92946127 |
| 36 | killing of cells of other organism (GO:0031640) | 3.92946127 |
| 37 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.85887092 |
| 38 | DNA replication initiation (GO:0006270) | 3.84972937 |
| 39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.83160083 |
| 40 | response to host immune response (GO:0052572) | 3.82603654 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.82603654 |
| 42 | viral transcription (GO:0019083) | 3.81144607 |
| 43 | positive regulation of mast cell activation (GO:0033005) | 3.77398442 |
| 44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.77146598 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.77146598 |
| 46 | negative regulation of growth of symbiont in host (GO:0044130) | 3.76667170 |
| 47 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.76667170 |
| 48 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.76667170 |
| 49 | regulation of growth of symbiont in host (GO:0044126) | 3.76667170 |
| 50 | translational termination (GO:0006415) | 3.71488979 |
| 51 | mitotic recombination (GO:0006312) | 3.70337482 |
| 52 | granulocyte activation (GO:0036230) | 3.70112280 |
| 53 | microglial cell activation (GO:0001774) | 3.63673380 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.63494979 |
| 55 | NADPH regeneration (GO:0006740) | 3.61288424 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.58933137 |
| 57 | B cell mediated immunity (GO:0019724) | 3.56140966 |
| 58 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.54561606 |
| 59 | DNA deamination (GO:0045006) | 3.53242062 |
| 60 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.51141260 |
| 61 | response to host (GO:0075136) | 3.51141260 |
| 62 | response to host defenses (GO:0052200) | 3.51141260 |
| 63 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.51022359 |
| 64 | positive regulation of mast cell degranulation (GO:0043306) | 3.51022359 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50534155 |
| 66 | cotranslational protein targeting to membrane (GO:0006613) | 3.45996742 |
| 67 | translational elongation (GO:0006414) | 3.44266309 |
| 68 | protein targeting to ER (GO:0045047) | 3.43587544 |
| 69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.43250742 |
| 70 | myeloid leukocyte mediated immunity (GO:0002444) | 3.39961205 |
| 71 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.32804686 |
| 72 | respiratory burst (GO:0045730) | 3.32708990 |
| 73 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32224962 |
| 74 | protein localization to chromosome, centromeric region (GO:0071459) | 3.31421298 |
| 75 | regulation of leukocyte degranulation (GO:0043300) | 3.31231885 |
| 76 | macrophage activation (GO:0042116) | 3.30451528 |
| 77 | telomere maintenance via telomere lengthening (GO:0010833) | 3.30146598 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29437072 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.28802827 |
| 80 | regulation of B cell differentiation (GO:0045577) | 3.27576886 |
| 81 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.27318187 |
| 82 | IMP metabolic process (GO:0046040) | 3.25905059 |
| 83 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.25771729 |
| 84 | protein localization to endoplasmic reticulum (GO:0070972) | 3.24627205 |
| 85 | DNA replication checkpoint (GO:0000076) | 3.23858884 |
| 86 | regulation of mast cell activation (GO:0033003) | 3.23772315 |
| 87 | IMP biosynthetic process (GO:0006188) | 3.23319423 |
| 88 | nucleobase biosynthetic process (GO:0046112) | 3.20719290 |
| 89 | ribosomal small subunit biogenesis (GO:0042274) | 3.20590226 |
| 90 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.20416937 |
| 91 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.18165082 |
| 92 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15765209 |
| 93 | leukocyte degranulation (GO:0043299) | 3.12985163 |
| 94 | B cell receptor signaling pathway (GO:0050853) | 3.08748999 |
| 95 | positive regulation of leukocyte degranulation (GO:0043302) | 3.07765401 |
| 96 | formation of translation preinitiation complex (GO:0001731) | 3.07046299 |
| 97 | negative regulation of T cell mediated immunity (GO:0002710) | 3.05477721 |
| 98 | maturation of SSU-rRNA (GO:0030490) | 3.05004277 |
| 99 | sequestering of metal ion (GO:0051238) | 3.03276203 |
| 100 | mitotic chromosome condensation (GO:0007076) | 3.03212985 |
| 101 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.00460744 |
| 102 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99558574 |
| 103 | response to muramyl dipeptide (GO:0032495) | 2.97286733 |
| 104 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96985312 |
| 105 | translational initiation (GO:0006413) | 2.96185245 |
| 106 | cellular protein complex disassembly (GO:0043624) | 2.95235781 |
| 107 | cellular response to zinc ion (GO:0071294) | 2.93873850 |
| 108 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.91708503 |
| 109 | viral life cycle (GO:0019058) | 2.91273732 |
| 110 | cell wall macromolecule catabolic process (GO:0016998) | 2.90576745 |
| 111 | pinocytosis (GO:0006907) | 2.89528291 |
| 112 | leukocyte mediated cytotoxicity (GO:0001909) | 2.86827519 |
| 113 | mitotic nuclear envelope disassembly (GO:0007077) | 2.86661947 |
| 114 | CENP-A containing nucleosome assembly (GO:0034080) | 2.85660151 |
| 115 | DNA topological change (GO:0006265) | 2.85128018 |
| 116 | regulation of tolerance induction (GO:0002643) | 2.84980643 |
| 117 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.84292964 |
| 118 | negative regulation of interleukin-17 production (GO:0032700) | 2.82641508 |
| 119 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.79483428 |
| 120 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.79292823 |
| 121 | regulation of protein heterodimerization activity (GO:0043497) | 2.77492001 |
| 122 | neutrophil chemotaxis (GO:0030593) | 2.77397352 |
| 123 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.77078601 |
| 124 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76686218 |
| 125 | neutrophil activation involved in immune response (GO:0002283) | 2.75730738 |
| 126 | DNA duplex unwinding (GO:0032508) | 2.75033904 |
| 127 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.74346383 |
| 128 | positive thymic T cell selection (GO:0045059) | 2.73872630 |
| 129 | myeloid leukocyte activation (GO:0002274) | 2.72475534 |
| 130 | kinetochore organization (GO:0051383) | 2.72110887 |
| 131 | actin nucleation (GO:0045010) | 2.71876989 |
| 132 | chromatin remodeling at centromere (GO:0031055) | 2.71487333 |
| 133 | defense response to protozoan (GO:0042832) | 2.71133320 |
| 134 | protein complex disassembly (GO:0043241) | 2.70533488 |
| 135 | neutrophil migration (GO:1990266) | 2.70476489 |
| 136 | DNA geometric change (GO:0032392) | 2.70319638 |
| 137 | mitotic sister chromatid segregation (GO:0000070) | 2.70045252 |
| 138 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.69546193 |
| 139 | telomere maintenance (GO:0000723) | 2.69371799 |
| 140 | amino sugar catabolic process (GO:0046348) | 2.68939564 |
| 141 | glycosphingolipid catabolic process (GO:0046479) | 2.68832031 |
| 142 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.68239815 |
| 143 | positive regulation of interferon-alpha production (GO:0032727) | 2.68227701 |
| 144 | telomere organization (GO:0032200) | 2.67625903 |
| 145 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.67612023 |
| 146 | cellular extravasation (GO:0045123) | 2.66714533 |
| 147 | macrophage differentiation (GO:0030225) | 2.66325660 |
| 148 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.66172451 |
| 149 | response to peptidoglycan (GO:0032494) | 2.64781678 |
| 150 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.64232021 |
| 151 | translesion synthesis (GO:0019985) | 2.63768694 |
| 152 | negative regulation of RNA splicing (GO:0033119) | 2.61812166 |
| 153 | regulation of interleukin-17 production (GO:0032660) | 2.61674204 |
| 154 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.61622199 |
| 155 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.61405584 |
| 156 | glucose catabolic process (GO:0006007) | 2.61044289 |
| 157 | purine nucleobase biosynthetic process (GO:0009113) | 2.60929887 |
| 158 | positive regulation of B cell differentiation (GO:0045579) | 2.60861488 |
| 159 | nuclear envelope disassembly (GO:0051081) | 2.60251887 |
| 160 | membrane disassembly (GO:0030397) | 2.60251887 |
| 161 | oligosaccharide catabolic process (GO:0009313) | 2.59729671 |
| 162 | sister chromatid segregation (GO:0000819) | 2.59551853 |
| 163 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58292626 |
| 164 | regulation of regulated secretory pathway (GO:1903305) | 2.58121309 |
| 165 | histone-serine phosphorylation (GO:0035404) | 2.56651006 |
| 166 | regulation of superoxide anion generation (GO:0032928) | 2.56213495 |
| 167 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.55767483 |
| 168 | negative regulation of innate immune response (GO:0045824) | 2.55451462 |
| 169 | regulation of spindle organization (GO:0090224) | 2.55389497 |
| 170 | mast cell activation (GO:0045576) | 2.54465321 |
| 171 | positive regulation of lamellipodium assembly (GO:0010592) | 2.52238763 |
| 172 | macromolecular complex disassembly (GO:0032984) | 2.51863426 |
| 173 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.51209073 |
| 174 | DNA replication-independent nucleosome organization (GO:0034724) | 2.51209073 |
| 175 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50841895 |
| 176 | positive regulation of antigen processing and presentation (GO:0002579) | 2.50089401 |
| 177 | negative thymic T cell selection (GO:0045060) | 2.49769913 |
| 178 | regulation of T cell tolerance induction (GO:0002664) | 2.49336276 |
| 179 | dendritic cell migration (GO:0036336) | 2.47886370 |
| 180 | regulation of antigen processing and presentation (GO:0002577) | 2.47857554 |
| 181 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.47104385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.35125484 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.75181245 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.65972436 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.19002543 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.04838715 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.88082620 |
| 7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.63644870 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.57161903 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.52361739 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.51356916 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47077232 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.44669777 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.32121244 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.26848369 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23119913 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.15582351 |
| 17 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.14458050 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.11550338 |
| 19 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08122348 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.06861572 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02418294 |
| 22 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.98169019 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.97075924 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.95142473 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93896533 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.90571065 |
| 27 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.86993066 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.86094676 |
| 29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.85855842 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84716797 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.84591730 |
| 32 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83125511 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82935283 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82790252 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82698809 |
| 36 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80147537 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79433973 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.78224957 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75129578 |
| 40 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.74924635 |
| 41 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.74711082 |
| 42 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73457102 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73341376 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72748282 |
| 45 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.71409219 |
| 46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.63878214 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61476388 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61412126 |
| 49 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.61032268 |
| 50 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60304503 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60100906 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.58186559 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51430360 |
| 54 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.51357112 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50688718 |
| 56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.49890579 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47815012 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.47508600 |
| 59 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46085868 |
| 60 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43052103 |
| 61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42976924 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42706826 |
| 63 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.42491452 |
| 64 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39571705 |
| 65 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.37371950 |
| 66 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.37129283 |
| 67 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35997075 |
| 68 | MYB_26560356_Chip-Seq_TH1_Human | 1.35829995 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35779851 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35127470 |
| 71 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34367912 |
| 72 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31654701 |
| 73 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.29718415 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28763543 |
| 75 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27620215 |
| 76 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25294739 |
| 77 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.24537120 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23198711 |
| 79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23027351 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20377032 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19562037 |
| 82 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17923489 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17540282 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16576297 |
| 85 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16268739 |
| 86 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.15734162 |
| 87 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14470428 |
| 88 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12642093 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12168986 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10401663 |
| 91 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.10075292 |
| 92 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09683854 |
| 93 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08969561 |
| 94 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08910332 |
| 95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08180116 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07363303 |
| 97 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06264161 |
| 98 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05834792 |
| 99 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04833316 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03870463 |
| 101 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03644167 |
| 102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03540165 |
| 103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02698809 |
| 104 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02621478 |
| 105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01983339 |
| 106 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01741174 |
| 107 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01566100 |
| 108 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01221995 |
| 109 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00701450 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98791557 |
| 111 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97944640 |
| 112 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97130620 |
| 113 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97007290 |
| 114 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96719548 |
| 115 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95373906 |
| 116 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94485161 |
| 117 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94146822 |
| 118 | MAF_26560356_Chip-Seq_TH2_Human | 0.93035670 |
| 119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92566582 |
| 120 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.91379561 |
| 121 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.91379561 |
| 122 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.91379561 |
| 123 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90193275 |
| 124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89838845 |
| 125 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89633092 |
| 126 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88724605 |
| 127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87191797 |
| 128 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.81255380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.62021619 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.45052165 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.13277813 |
| 4 | MP0003436_decreased_susceptibility_to | 2.84611639 |
| 5 | MP0009785_altered_susceptibility_to | 2.71515662 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.69741585 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.61667167 |
| 8 | MP0008260_abnormal_autophagy | 2.57742898 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 2.54717907 |
| 10 | MP0003077_abnormal_cell_cycle | 2.51516163 |
| 11 | MP0008057_abnormal_DNA_replication | 2.42846221 |
| 12 | MP0003303_peritoneal_inflammation | 2.42479663 |
| 13 | MP0006082_CNS_inflammation | 2.38948965 |
| 14 | MP0000490_abnormal_crypts_of | 2.36004036 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.35360824 |
| 16 | MP0004808_abnormal_hematopoietic_stem | 2.30062186 |
| 17 | MP0006054_spinal_hemorrhage | 2.25528203 |
| 18 | MP0002419_abnormal_innate_immunity | 2.22238598 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.19864947 |
| 20 | MP0005025_abnormal_response_to | 2.18220330 |
| 21 | MP0002398_abnormal_bone_marrow | 2.12357458 |
| 22 | MP0005671_abnormal_response_to | 2.10752722 |
| 23 | MP0003828_pulmonary_edema | 2.10000564 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.05371923 |
| 25 | MP0001819_abnormal_immune_cell | 2.02810941 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.01169018 |
| 27 | MP0000685_abnormal_immune_system | 1.99078452 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.94785270 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.94256668 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.90861400 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.90142443 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.88488693 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.87071545 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.87071545 |
| 35 | MP0001800_abnormal_humoral_immune | 1.86623739 |
| 36 | MP0002722_abnormal_immune_system | 1.84110297 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.83675310 |
| 38 | MP0000716_abnormal_immune_system | 1.81882825 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.77886972 |
| 40 | MP0002429_abnormal_blood_cell | 1.73980305 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.73095684 |
| 42 | MP0002723_abnormal_immune_serum | 1.72666420 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.71784247 |
| 44 | MP0002405_respiratory_system_inflammati | 1.71508053 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.68895989 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.68834009 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.67270314 |
| 48 | MP0010307_abnormal_tumor_latency | 1.65727877 |
| 49 | MP0000858_altered_metastatic_potential | 1.64978287 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.63125448 |
| 51 | MP0008058_abnormal_DNA_repair | 1.62236547 |
| 52 | MP0003724_increased_susceptibility_to | 1.57994146 |
| 53 | MP0001853_heart_inflammation | 1.57722569 |
| 54 | MP0002006_tumorigenesis | 1.53198675 |
| 55 | * MP0002148_abnormal_hypersensitivity_rea | 1.49553712 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.49210591 |
| 57 | MP0004883_abnormal_blood_vessel | 1.48439203 |
| 58 | MP0001873_stomach_inflammation | 1.47765019 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.41030124 |
| 60 | * MP0001845_abnormal_inflammatory_respons | 1.35289421 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.34291641 |
| 62 | MP0003866_abnormal_defecation | 1.31990512 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.29979754 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.29898591 |
| 65 | MP0005387_immune_system_phenotype | 1.26641961 |
| 66 | MP0001790_abnormal_immune_system | 1.26641961 |
| 67 | MP0009278_abnormal_bone_marrow | 1.23680862 |
| 68 | MP0000350_abnormal_cell_proliferation | 1.22689161 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.22670174 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.20273664 |
| 71 | MP0000604_amyloidosis | 1.19549755 |
| 72 | MP0000343_altered_response_to | 1.14721322 |
| 73 | MP0005310_abnormal_salivary_gland | 1.14220072 |
| 74 | MP0001730_embryonic_growth_arrest | 1.13163930 |
| 75 | MP0009764_decreased_sensitivity_to | 1.11712699 |
| 76 | MP0000313_abnormal_cell_death | 1.11382600 |
| 77 | MP0008932_abnormal_embryonic_tissue | 1.11100300 |
| 78 | MP0005164_abnormal_response_to | 1.05601635 |
| 79 | MP0000569_abnormal_digit_pigmentation | 1.04636920 |
| 80 | MP0005451_abnormal_body_composition | 1.03527528 |
| 81 | MP0003690_abnormal_glial_cell | 1.01170398 |
| 82 | MP0002009_preneoplasia | 1.00331783 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.99438870 |
| 84 | MP0005023_abnormal_wound_healing | 0.96899535 |
| 85 | MP0003123_paternal_imprinting | 0.94639048 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94079092 |
| 87 | MP0001663_abnormal_digestive_system | 0.93290958 |
| 88 | MP0008469_abnormal_protein_level | 0.93252946 |
| 89 | MP0003186_abnormal_redox_activity | 0.92854880 |
| 90 | MP0003075_altered_response_to | 0.92000059 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.91225372 |
| 92 | MP0001851_eye_inflammation | 0.89074662 |
| 93 | MP0002132_abnormal_respiratory_system | 0.88110014 |
| 94 | MP0002080_prenatal_lethality | 0.87197948 |
| 95 | MP0004947_skin_inflammation | 0.85838808 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.85663199 |
| 97 | MP0000371_diluted_coat_color | 0.85183538 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 0.85153544 |
| 99 | MP0004381_abnormal_hair_follicle | 0.84611546 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.84192576 |
| 101 | MP0009763_increased_sensitivity_to | 0.83606312 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.81565825 |
| 103 | MP0003448_altered_tumor_morphology | 0.81307770 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.78625363 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.77952654 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.77043704 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76485866 |
| 108 | MP0002933_joint_inflammation | 0.76248898 |
| 109 | MP0005388_respiratory_system_phenotype | 0.76131284 |
| 110 | MP0002133_abnormal_respiratory_system | 0.76131284 |
| 111 | MP0005166_decreased_susceptibility_to | 0.75839143 |
| 112 | MP0000477_abnormal_intestine_morphology | 0.74895759 |
| 113 | MP0001697_abnormal_embryo_size | 0.74729386 |
| 114 | MP0003786_premature_aging | 0.74445276 |
| 115 | MP0000358_abnormal_cell_content/ | 0.74281127 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.74276260 |
| 117 | MP0002089_abnormal_postnatal_growth/wei | 0.74165717 |
| 118 | MP0008873_increased_physiological_sensi | 0.68638511 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.68359852 |
| 120 | MP0009840_abnormal_foam_cell | 0.67991114 |
| 121 | MP0003984_embryonic_growth_retardation | 0.67328698 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.67031505 |
| 123 | MP0000249_abnormal_blood_vessel | 0.65407495 |
| 124 | MP0002086_abnormal_extraembryonic_tissu | 0.65194077 |
| 125 | MP0002088_abnormal_embryonic_growth/wei | 0.63805033 |
| 126 | MP0002254_reproductive_system_inflammat | 0.63772267 |
| 127 | MP0003795_abnormal_bone_structure | 0.63481544 |
| 128 | MP0008004_abnormal_stomach_pH | 0.59445925 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.58913601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 5.59360914 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.80028987 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.80028987 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.80028987 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.51370225 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.41863416 |
| 7 | Reticulocytopenia (HP:0001896) | 4.03661629 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.91723546 |
| 9 | Optic neuritis (HP:0100653) | 3.91723546 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.83389235 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.76681425 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.72738498 |
| 13 | IgM deficiency (HP:0002850) | 3.71773516 |
| 14 | Stomatitis (HP:0010280) | 3.66062015 |
| 15 | Obstructive lung disease (HP:0006536) | 3.64603342 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.64603342 |
| 17 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.61172475 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.60329401 |
| 19 | B lymphocytopenia (HP:0010976) | 3.53422590 |
| 20 | Abnormality of B cell number (HP:0010975) | 3.53422590 |
| 21 | Aplastic anemia (HP:0001915) | 3.48451006 |
| 22 | Myositis (HP:0100614) | 3.32490723 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.09542029 |
| 24 | Meningitis (HP:0001287) | 3.06680506 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.06164942 |
| 26 | Disinhibition (HP:0000734) | 3.05115218 |
| 27 | Recurrent viral infections (HP:0004429) | 3.04608729 |
| 28 | Eosinophilia (HP:0001880) | 3.00108341 |
| 29 | Granulocytopenia (HP:0001913) | 2.99845113 |
| 30 | Petechiae (HP:0000967) | 2.99755608 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 2.99271500 |
| 32 | Keratoconjunctivitis sicca (HP:0001097) | 2.98147410 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91804295 |
| 34 | Periodontitis (HP:0000704) | 2.90800309 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89139938 |
| 36 | Encephalitis (HP:0002383) | 2.85512022 |
| 37 | Reduced antithrombin III activity (HP:0001976) | 2.81422768 |
| 38 | Abnormality of the prostate (HP:0008775) | 2.78536726 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.77593164 |
| 40 | Loss of speech (HP:0002371) | 2.76124690 |
| 41 | Abnormality of T cells (HP:0002843) | 2.75958225 |
| 42 | Cellulitis (HP:0100658) | 2.75032800 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.74493470 |
| 44 | Chest pain (HP:0100749) | 2.72590716 |
| 45 | Chronic otitis media (HP:0000389) | 2.69091542 |
| 46 | Myocardial infarction (HP:0001658) | 2.67076031 |
| 47 | Poikiloderma (HP:0001029) | 2.67012462 |
| 48 | Hepatosplenomegaly (HP:0001433) | 2.58640086 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.55891532 |
| 50 | Amyloidosis (HP:0011034) | 2.54313716 |
| 51 | Gingival bleeding (HP:0000225) | 2.53506390 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 2.52121400 |
| 53 | Pustule (HP:0200039) | 2.50958158 |
| 54 | Arterial thrombosis (HP:0004420) | 2.49562825 |
| 55 | Recurrent skin infections (HP:0001581) | 2.49083170 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.46582104 |
| 57 | Leukocytosis (HP:0001974) | 2.46406235 |
| 58 | Anorexia (HP:0002039) | 2.46350250 |
| 59 | Cutaneous melanoma (HP:0012056) | 2.45560589 |
| 60 | Myelodysplasia (HP:0002863) | 2.43702204 |
| 61 | Papilledema (HP:0001085) | 2.43090118 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.42412072 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.40035424 |
| 64 | Abnormality of eosinophils (HP:0001879) | 2.36078377 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.34990551 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.33030328 |
| 67 | Epistaxis (HP:0000421) | 2.29794645 |
| 68 | Chromsome breakage (HP:0040012) | 2.26462805 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.23278469 |
| 70 | Viral hepatitis (HP:0006562) | 2.23121077 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22363666 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21395601 |
| 73 | 11 pairs of ribs (HP:0000878) | 2.21224630 |
| 74 | Recurrent bronchitis (HP:0002837) | 2.19416565 |
| 75 | Hemoptysis (HP:0002105) | 2.19221752 |
| 76 | Premature loss of primary teeth (HP:0006323) | 2.18788266 |
| 77 | Lymphopenia (HP:0001888) | 2.18220245 |
| 78 | Neutropenia (HP:0001875) | 2.17537675 |
| 79 | Panhypogammaglobulinemia (HP:0003139) | 2.16814779 |
| 80 | Pallor (HP:0000980) | 2.15711407 |
| 81 | Abnormal protein glycosylation (HP:0012346) | 2.14827901 |
| 82 | Abnormal glycosylation (HP:0012345) | 2.14827901 |
| 83 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.14827901 |
| 84 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.14827901 |
| 85 | Entropion (HP:0000621) | 2.12911439 |
| 86 | Amaurosis fugax (HP:0100576) | 2.11833630 |
| 87 | Lymphoma (HP:0002665) | 2.11424626 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.11268013 |
| 89 | Agnosia (HP:0010524) | 2.10053115 |
| 90 | Skin ulcer (HP:0200042) | 2.09626289 |
| 91 | Macrocytic anemia (HP:0001972) | 2.09573345 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 2.09030561 |
| 93 | Oral leukoplakia (HP:0002745) | 2.08812346 |
| 94 | Abnormal platelet volume (HP:0011876) | 2.08686931 |
| 95 | Pulmonary embolism (HP:0002204) | 2.08179694 |
| 96 | Abnormality of DNA repair (HP:0003254) | 2.07524883 |
| 97 | Abnormal platelet function (HP:0011869) | 2.07408218 |
| 98 | Impaired platelet aggregation (HP:0003540) | 2.07408218 |
| 99 | Pulmonary fibrosis (HP:0002206) | 2.07263950 |
| 100 | Prostate neoplasm (HP:0100787) | 2.07130065 |
| 101 | Bone marrow hypocellularity (HP:0005528) | 2.05451511 |
| 102 | Osteomyelitis (HP:0002754) | 2.05157640 |
| 103 | Abnormality of the pleura (HP:0002103) | 2.05092401 |
| 104 | Prolonged bleeding time (HP:0003010) | 2.05073271 |
| 105 | Colitis (HP:0002583) | 2.02648176 |
| 106 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01555468 |
| 107 | Abnormality of the anterior horn cell (HP:0006802) | 2.00716127 |
| 108 | Degeneration of anterior horn cells (HP:0002398) | 2.00716127 |
| 109 | T lymphocytopenia (HP:0005403) | 2.00400913 |
| 110 | Vasculitis (HP:0002633) | 1.99436281 |
| 111 | Increased IgM level (HP:0003496) | 1.99419463 |
| 112 | Orchitis (HP:0100796) | 1.99279552 |
| 113 | Abnormality of chromosome stability (HP:0003220) | 1.98925438 |
| 114 | Gingivitis (HP:0000230) | 1.98629628 |
| 115 | Dysostosis multiplex (HP:0000943) | 1.98253449 |
| 116 | Gangrene (HP:0100758) | 1.97829022 |
| 117 | Combined immunodeficiency (HP:0005387) | 1.96500870 |
| 118 | Birth length less than 3rd percentile (HP:0003561) | 1.94707146 |
| 119 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.94699419 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 1.92852344 |
| 121 | Pancytopenia (HP:0001876) | 1.91391258 |
| 122 | Subacute progressive viral hepatitis (HP:0006572) | 1.91195647 |
| 123 | Severe combined immunodeficiency (HP:0004430) | 1.91090458 |
| 124 | Urticaria (HP:0001025) | 1.91073483 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 1.90314946 |
| 126 | Basal cell carcinoma (HP:0002671) | 1.88688097 |
| 127 | Recurrent cutaneous fungal infections (HP:0011370) | 1.88505834 |
| 128 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.88505834 |
| 129 | Ureteral stenosis (HP:0000071) | 1.87872136 |
| 130 | Premature graying of hair (HP:0002216) | 1.87423071 |
| 131 | Abnormality of T cell number (HP:0011839) | 1.87314646 |
| 132 | Acute myeloid leukemia (HP:0004808) | 1.86874527 |
| 133 | Sepsis (HP:0100806) | 1.86414557 |
| 134 | Glomerulopathy (HP:0100820) | 1.86199107 |
| 135 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.85590753 |
| 136 | High pitched voice (HP:0001620) | 1.85530613 |
| 137 | IgG deficiency (HP:0004315) | 1.85349053 |
| 138 | Recurrent pneumonia (HP:0006532) | 1.85086643 |
| 139 | Abnormality of the thoracic spine (HP:0100711) | 1.84895103 |
| 140 | Hematochezia (HP:0002573) | 1.83192697 |
| 141 | Vacuolated lymphocytes (HP:0001922) | 1.80568893 |
| 142 | Polyneuropathy (HP:0001271) | 1.79224088 |
| 143 | Increased serum ferritin (HP:0003281) | 1.79155277 |
| 144 | Fatigue (HP:0012378) | 1.76250586 |
| 145 | Episodic fever (HP:0001954) | 1.75213699 |
| 146 | Abnormality of iron homeostasis (HP:0011031) | 1.74962716 |
| 147 | Microcytic anemia (HP:0001935) | 1.74010492 |
| 148 | Thrombophlebitis (HP:0004418) | 1.73741091 |
| 149 | Agammaglobulinemia (HP:0004432) | 1.71401157 |
| 150 | Increased IgE level (HP:0003212) | 1.70950015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.60663654 |
| 2 | MAP4K1 | 2.90530836 |
| 3 | WEE1 | 2.88535505 |
| 4 | BUB1 | 2.83937023 |
| 5 | CDC7 | 2.75424848 |
| 6 | IRAK4 | 2.66891610 |
| 7 | FGR | 2.65727744 |
| 8 | EEF2K | 2.65594575 |
| 9 | TESK2 | 2.54993853 |
| 10 | PKN2 | 2.46920999 |
| 11 | STK16 | 2.24631582 |
| 12 | TESK1 | 2.09190196 |
| 13 | BMPR2 | 2.07029112 |
| 14 | CDK19 | 2.05500258 |
| 15 | EIF2AK3 | 1.97467989 |
| 16 | BTK | 1.89855598 |
| 17 | MAP3K13 | 1.88344987 |
| 18 | NEK2 | 1.77739483 |
| 19 | FLT3 | 1.68112751 |
| 20 | TEC | 1.68031900 |
| 21 | BLK | 1.64029900 |
| 22 | BRSK2 | 1.61698616 |
| 23 | ZAP70 | 1.61473855 |
| 24 | GRK6 | 1.58675777 |
| 25 | STK10 | 1.58028987 |
| 26 | ERN1 | 1.55347742 |
| 27 | MAP2K3 | 1.54095032 |
| 28 | TRIB3 | 1.52716852 |
| 29 | TGFBR1 | 1.48839270 |
| 30 | PIM2 | 1.48015490 |
| 31 | PRPF4B | 1.47452019 |
| 32 | KDR | 1.47319805 |
| 33 | RPS6KB2 | 1.46909342 |
| 34 | PASK | 1.44677231 |
| 35 | LRRK2 | 1.38486839 |
| 36 | EIF2AK1 | 1.37351844 |
| 37 | CLK1 | 1.37182893 |
| 38 | MAP3K10 | 1.37065194 |
| 39 | ACVR1B | 1.36476654 |
| 40 | VRK1 | 1.36298436 |
| 41 | PAK4 | 1.36081653 |
| 42 | YES1 | 1.35310086 |
| 43 | TXK | 1.35058741 |
| 44 | KIT | 1.32556101 |
| 45 | FES | 1.29646965 |
| 46 | MAP3K12 | 1.28621667 |
| 47 | TSSK6 | 1.26134749 |
| 48 | JAK1 | 1.18794498 |
| 49 | TAOK3 | 1.17855183 |
| 50 | ATR | 1.17349205 |
| 51 | JAK3 | 1.16199591 |
| 52 | SCYL2 | 1.16071593 |
| 53 | NME2 | 1.12591664 |
| 54 | SYK | 1.10476638 |
| 55 | SRPK1 | 1.10458204 |
| 56 | JAK2 | 1.10403039 |
| 57 | CDK7 | 1.09868543 |
| 58 | TYK2 | 1.09752828 |
| 59 | MAP3K8 | 1.09621672 |
| 60 | MST4 | 1.06558729 |
| 61 | MARK3 | 1.06057246 |
| 62 | MAP3K3 | 1.04853249 |
| 63 | TNK2 | 1.03015731 |
| 64 | CDK4 | 1.02758178 |
| 65 | LIMK1 | 0.99942213 |
| 66 | NEK1 | 0.99340188 |
| 67 | ITK | 0.98450466 |
| 68 | RPS6KA4 | 0.96389503 |
| 69 | PIM1 | 0.94973636 |
| 70 | AURKB | 0.94789824 |
| 71 | MAP3K11 | 0.93207765 |
| 72 | ILK | 0.92998659 |
| 73 | STK4 | 0.89584776 |
| 74 | CSF1R | 0.89349224 |
| 75 | PBK | 0.89003647 |
| 76 | BRSK1 | 0.87513067 |
| 77 | MAPKAPK3 | 0.87448210 |
| 78 | PLK1 | 0.85117426 |
| 79 | SMG1 | 0.84713227 |
| 80 | MKNK1 | 0.83459107 |
| 81 | MAP3K6 | 0.83251840 |
| 82 | CDK8 | 0.82253055 |
| 83 | IKBKB | 0.81832667 |
| 84 | TBK1 | 0.81448806 |
| 85 | NEK9 | 0.80210007 |
| 86 | TRPM7 | 0.79617527 |
| 87 | SIK3 | 0.77677607 |
| 88 | CCNB1 | 0.76622973 |
| 89 | ALK | 0.75869391 |
| 90 | TGFBR2 | 0.75312973 |
| 91 | LYN | 0.74780666 |
| 92 | TLK1 | 0.74731932 |
| 93 | MAP3K1 | 0.72786737 |
| 94 | STK24 | 0.71879532 |
| 95 | NUAK1 | 0.70288619 |
| 96 | LCK | 0.70136337 |
| 97 | IRAK1 | 0.68655809 |
| 98 | IRAK2 | 0.67739128 |
| 99 | KSR2 | 0.67392447 |
| 100 | PIK3CG | 0.66528177 |
| 101 | PDK2 | 0.66315135 |
| 102 | HCK | 0.65437209 |
| 103 | CSK | 0.65412831 |
| 104 | MAPK4 | 0.64877222 |
| 105 | TTK | 0.63388259 |
| 106 | MAPK11 | 0.61609706 |
| 107 | VRK2 | 0.60774526 |
| 108 | CDK6 | 0.58634578 |
| 109 | RPS6KA6 | 0.58277155 |
| 110 | RPS6KC1 | 0.56770325 |
| 111 | RPS6KL1 | 0.56770325 |
| 112 | PDK1 | 0.56491431 |
| 113 | EPHB1 | 0.54368286 |
| 114 | MYLK | 0.53887739 |
| 115 | PLK4 | 0.53835803 |
| 116 | TAF1 | 0.53405522 |
| 117 | DAPK1 | 0.52271550 |
| 118 | FYN | 0.52042617 |
| 119 | NLK | 0.50876413 |
| 120 | IKBKE | 0.50826547 |
| 121 | BRD4 | 0.50440367 |
| 122 | PTK6 | 0.50124231 |
| 123 | MAP2K6 | 0.48688933 |
| 124 | RAF1 | 0.48199219 |
| 125 | EGFR | 0.47629433 |
| 126 | BCKDK | 0.47420083 |
| 127 | MAP3K14 | 0.46752891 |
| 128 | MATK | 0.46477426 |
| 129 | MAP3K5 | 0.46350707 |
| 130 | TTN | 0.45409406 |
| 131 | PDPK1 | 0.45405587 |
| 132 | DYRK3 | 0.44309827 |
| 133 | CHEK1 | 0.41992373 |
| 134 | PAK1 | 0.41486057 |
| 135 | EIF2AK2 | 0.40218615 |
| 136 | NEK6 | 0.40153340 |
| 137 | CHEK2 | 0.38654313 |
| 138 | ZAK | 0.37422577 |
| 139 | MAP3K2 | 0.36892212 |
| 140 | MAPKAPK2 | 0.36290553 |
| 141 | CSNK2A1 | 0.35626552 |
| 142 | PRKCQ | 0.35522472 |
| 143 | AURKA | 0.34980055 |
| 144 | MAPK7 | 0.34126760 |
| 145 | FGFR3 | 0.34051098 |
| 146 | MAP2K2 | 0.29977561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.15635237 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.65743058 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.15747051 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.14804635 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.92068058 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.60520880 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50569771 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.49488997 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.39664149 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.38788656 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.23882618 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.17940140 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.10181173 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.08722436 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 2.08624920 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 2.02096290 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.97737707 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.86210734 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83773649 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.80514065 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79348093 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.74572330 |
| 23 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.71602231 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.69889543 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.67786232 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.63710051 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.59653097 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58762250 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.49937574 |
| 30 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.39501365 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39412666 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29224146 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.26074553 |
| 34 | Protein export_Homo sapiens_hsa03060 | 1.25653487 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.24943938 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20966247 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20752043 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.20138345 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19032313 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.18841425 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18105794 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16006621 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14792321 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.14720247 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12322571 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.10274815 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09504528 |
| 48 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.02670492 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96818579 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95426381 |
| 51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94809668 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91850228 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90099612 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89800566 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89083280 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.88429184 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87645313 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86979273 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86563896 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83805779 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83463140 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82170380 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82012696 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79757671 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77668432 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.77523567 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77189118 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76785497 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76465300 |
| 70 | Purine metabolism_Homo sapiens_hsa00230 | 0.76217105 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74822788 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74713495 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74377742 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74364549 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73969819 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73491384 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71524330 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71271055 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70908092 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69629984 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.69286501 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68928369 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68797396 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68625437 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68353812 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.68330352 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66561232 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66028981 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.65854029 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64497616 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64422167 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61727510 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.61671285 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.60998168 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60807387 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60052848 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57692440 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56947966 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54474810 |
| 100 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53820829 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53801989 |
| 102 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53478362 |
| 103 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53013226 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.52618355 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52165529 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50756193 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50487518 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.49517172 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.47559157 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46432796 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45547570 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45463486 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45187015 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44251346 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43572931 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42972031 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42614399 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41550700 |
| 119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41169851 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39869849 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.39169323 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38461811 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37572948 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36262758 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.35995221 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29740091 |
| 127 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29140053 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26539767 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25643080 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24379650 |

